Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3915)
All Articles published online
|
Dec 15, 2011 (publication date) through Dec 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boj-Carceller D, Bocos-Terraz P, Moreno-Vernis M, Sanz-Paris A, Trincado-Aznar P, Albero-Gamboa R. Are proton pump inhibitors a new antidiabetic drug? A cross sectional study. World J Diabetes 2011; 2(12): 217-220 [PMID: 22174957 DOI: 10.4239/wjd.v2.i12.217] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v2/i12/217.htm |
| Number | Citing Articles |
| 1 |
Ilaria Barchetta, Chiara Guglielmi, Laura Bertoccini, Damiano Calella, Silvia Manfrini, Chiara Secchi, Paolo Pozzilli, Maria Gisella Cavallo. Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control. Acta Diabetologica 2015; 52(5): 873 doi: 10.1007/s00592-015-0721-4
|
| 2 |
K. D. Hove, C. Brøns, K. Færch, S. S. Lund, J. S. Petersen, A. E. Karlsen, P. Rossing, J. F. Rehfeld, A. Vaag. Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study. Diabetologia 2013; 56(1): 22 doi: 10.1007/s00125-012-2714-y
|
| 3 |
Christopher B. Chen, Mu Lin, Dean T. Eurich, Jeffrey A. Johnson. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study. Clinical Therapeutics 2016; 38(6): 1392 doi: 10.1016/j.clinthera.2016.03.024
|
| 4 |
Hsiu-Chen Lin, Yu-Ting Hsiao, Hsiu-Li Lin, Yow-Shieng Uang, Hui-Wen Cheng, Ying Wang, Li-Hsuan Wang. The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease. Medicine 2016; 95(28): e4195 doi: 10.1097/MD.0000000000004195
|
| 5 |
Carol Chiung-Hui Peng, Yu-Kang Tu, Gin Yi Lee, Rachel Huai-En Chang, Yuting Huang, Khulood Bukhari, Yao-Chou Tsai, Yunting Fu, Huei-Kai Huang, Kashif M Munir. Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism 2021; 106(11): 3354 doi: 10.1210/clinem/dgab353
|
| 6 |
AnHye Kim, Inbum Chung, Seo Hyun Yoon, Kyung-Sang Yu, Kyoung Soo Lim, Joo-Youn Cho, Howard Lee, In-Jin Jang, Jae Yong Chung. Effects of Proton Pump Inhibitors on Metformin Pharmacokinetics and Pharmacodynamics. Drug Metabolism and Disposition 2014; 42(7): 1174 doi: 10.1124/dmd.113.055616
|
| 7 |
Eivind Grong, Hallvard Græslie, Bjørn Munkvold, Ingerid Brænne Arbo, Bård Erik Kulseng, Helge L. Waldum, Ronald Mårvik. Gastrin Secretion After Bariatric Surgery—Response to a Protein-Rich Mixed Meal Following Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: a Pilot Study in Normoglycemic Women. Obesity Surgery 2016; 26(7): 1448 doi: 10.1007/s11695-015-1985-z
|
| 8 |
Natsuki Eguchi, Arvin John Toribio, Michael Alexander, Ivana Xu, David Lee Whaley, Luis F. Hernandez, Donald Dafoe, Hirohito Ichii. Dysregulation of β-Cell Proliferation in Diabetes: Possibilities of Combination Therapy in the Development of a Comprehensive Treatment. Biomedicines 2022; 10(2): 472 doi: 10.3390/biomedicines10020472
|
| 9 |
Diana Boj-Carceller. Proton pump inhibitors: impact on glucose metabolism. Endocrine 2013; 43(1): 22 doi: 10.1007/s12020-012-9755-3
|
| 10 |
Yi Liu, Yingting Wu, Mengxi Jiang. The emerging roles of PHOSPHO1 and its regulated phospholipid homeostasis in metabolic disorders. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.935195
|
| 11 |
ShaoJun Hao, JianHua Sun, XiKui Tian, Xu Sun, ZhenXing Zhang, Yuan Gao. Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects. Journal of Pharmacy and Pharmacology 2014; 66(8): 1133 doi: 10.1111/jphp.12237
|
| 12 |
Yusuf Bozkuş, Umut Mousa, Özlem T. İyidir, Nazlı Kırnap, Canan Ç. Demir, Aslı Nar, Neslihan B. Tütüncü. Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(7): 1090 doi: 10.2174/1871530320666200129124555
|
| 13 |
Paolo Pozzilli, Ernesto Maddaloni, Raffaella Buzzetti. Combination immunotherapies for type 1 diabetes mellitus. Nature Reviews Endocrinology 2015; 11(5): 289 doi: 10.1038/nrendo.2015.8
|
| 14 |
Menghua Luo, Anne C. Voss, Vikkie A. Mustad, Lyudmila Ivanova, Tatiana Morugova, Elena Alexeeva, Lyudmila Ruyatkina, Lyudmila Suplotova. Four-hour evaluation of a medical food in subjects with type 2 diabetes receiving oral hypoglycemic medication. Journal of Diabetes Mellitus 2012; 2(02): 214 doi: 10.4236/jdm.2012.22034
|
| 15 |
Muhammad Ali Rajput, Fizzah Ali, Tabassum Zehra, Shahid Zafar, Gunesh Kumar. The effect of proton pump inhibitors on glycaemic control in diabetic patients. Journal of Taibah University Medical Sciences 2020; 15(3): 218 doi: 10.1016/j.jtumed.2020.03.003
|
| 16 |
Kelly Villegas, Joy L. Meier, Maureen Long, Julio Lopez, Arthur Swislocki. The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Metabolic Syndrome and Related Disorders 2019; 17(4): 192 doi: 10.1089/met.2018.0138
|
| 17 |
Karla J. Suchacki, Nicholas M. Morton, Calvin Vary, Carmen Huesa, Manisha C. Yadav, Benjamin J. Thomas, Sophie Turban, Lutz Bunger, Derek Ball, Martin E. Barrios-Llerena, Anyonya R. Guntur, Zohreh Khavandgar, William P. Cawthorn, Mathieu Ferron, Gérard Karsenty, Monzur Murshed, Clifford J. Rosen, Vicky E. MacRae, Jose Luis Millán, Colin Farquharson. PHOSPHO1 is a skeletal regulator of insulin resistance and obesity. BMC Biology 2020; 18(1) doi: 10.1186/s12915-020-00880-7
|
| 18 |
F. Inci, M. Atmaca, M. Ozturk, S. Yildiz, R. Koceroglu, R. Sekeroglu, S. H. Ipekci, L. Kebapcilar. Pantoprazole may improve beta cell function and diabetes mellitus. Journal of Endocrinological Investigation 2014; 37(5): 449 doi: 10.1007/s40618-013-0040-y
|
| 19 |
Adriana Sánchez-García, Mario Simental-Mendía, Luis E. Simental-Mendía. Effect of Proton-Pump Inhibitors on Glucose and Insulin Metabolism on Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Pharmaceutical Design 2020; 26(32): 4007 doi: 10.2174/1381612826666200523170718
|
| 20 |
Satish K. Garg, Aaron W. Michels, Viral N. Shah. Use of Non-Insulin Therapies for Type 1 Diabetes. Diabetes Technology & Therapeutics 2013; 15(11): 901 doi: 10.1089/dia.2013.0281
|
| 21 |
Kohzo Takebayashi, Shintaro Sakurai, Tatsuhiko Suzuki, Kenichiro Hori, Tomoko Terasawa, Rika Naruse, Kenji Hara, Mariko Suetsugu, Takafumi Tsuchiya, Hiromi Aoki, Takashi Hamasaki, Hiroshi Shuutou, Toshihiko Inukai. Effect of combination therapy with alogliptin and lansoprazole on glycemic control in patients with type 2 diabetes. Endocrine Journal 2014; 61(10): 1031 doi: 10.1507/endocrj.EJ14-0208
|
| 22 |
Manuel González-Ortiz, Esperanza Martínez-Abundis, Arieh R. Mercado-Sesma, Rebeca Álvarez-Carrillo. Effect of pantoprazole on insulin secretion in drug-naïve patients with type 2 diabetes. Diabetes Research and Clinical Practice 2015; 108(1): e11 doi: 10.1016/j.diabres.2015.01.039
|
| 23 |
Baran ÖZDEMİR, Karya Başak ÖN, Ezgi ALTINER. UŞAK EĞİTİM VE ARAŞTIRMA HASTANESİ’NE BAŞVURAN HASTALARDA PROTON POMPA İNHİBİTÖRÜ KULLANIM YAYGINLIĞININ İNCELENMESİ. Ege Tıp Bilimleri Dergisi 2022; 5(1): 11 doi: 10.33713/egetbd.1070299
|
| 24 |
I. N. Mefford, J. T. Mefford, C. A. Burris. Improved Diabetes Control and Pancreatic Function in a Type 2 Diabetic after Omeprazole Administration. Case Reports in Endocrinology 2012; 2012: 1 doi: 10.1155/2012/468609
|
| 25 |
Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun. Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01051-8
|
| 26 |
Frederik Vandenberghe, Corinne Challet, Mathias Maitrejean, Laurent Christin, Nicolas Schaad. Impact of drugs on hypoglycaemia in hospitalised patients. European Journal of Hospital Pharmacy 2019; 26(4): 199 doi: 10.1136/ejhpharm-2017-001375
|
| 27 |
Francesco Zaccardi, Dario Pitocco, Francesca Martini, Salvatore Caputo, Luca Miele, Antonio Grieco, Giovanni Ghirlanda. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance. Acta Diabetologica 2014; 51(1): 151 doi: 10.1007/s00592-012-0382-5
|